spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Valentis 

 HSMN NewsFeed - 7 Aug 2017
Alkahest Appoints Helen Jenkins as Chief Operating Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 15 Nov 2007
Urigen Pharmaceuticals, Inc. Provides Corporate Update
Biopharmaceuticals Urology
 HSMN NewsFeed - 8 Nov 2007
Urigen Pharmaceuticals, Inc. Appoints Cynthia L. Sullivan and Robert J. Watkins to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Aug 2007
Inovio Biomedical Appoints Dr. Michael Fons as Vice President, Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jul 2007
Urigen Pharmaceuticals, Inc., formerly Valentis, Inc. Announces Name Change and New Stock Symbol
Biopharmaceuticals Urology
 HSMN NewsFeed - 20 Jul 2007
Biotechnology Start-up Nuon Therapeutics Inc. Completes $5 Million Series A Financing and Names Management Team
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 21 Jun 2007
NanoMed Pharmaceuticals Hires Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Apr 2007
Threshold Pharmaceuticals Appoints David R. Hoffmann to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jan 2007
Juvaris Announces First Round Closing of Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Jan 2007
Urigen N.A., Inc. Appoints Dennis Giesing, PhD As Director of Product Development
Biopharmaceuticals Urology Personnel
 HSMN NewsFeed - 29 Nov 2006
Urigen N.A., Inc. Appoints Terry M. Nida to Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Oct 2006
Inovio Biomedical Acquires Rights to DNA Vaccine Licenses and Intellectual Property from Valentis
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 29 Sep 2006
Celsion Obtains from Valentis Exclusive Rights to Pegylation Patents for use with Heat Activated Liposomes
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 17 Jul 2006
Endovasc Cites Favorable Market Conditions for its Liprostin Drug
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 15

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 15 additional stories matching:
Valentis
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.